Fintel reports that on March 10, 2025, D. Boral Capital initiated coverage of Pulmonx (NasdaqGS:LUNG) with a Buy ...
D. Boral Capital initiated coverage of Pulmonx (LUNG) with a Buy rating and $17 price target The firm says Pulmonx is a commercial-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results